The White House declared this week Overdose Awareness Week, boasting $22 billion of new investment to address the overdose crisis – including massive investments in “expanding access to life-saving medications.”

Telehealth treatment for opioid addiction is working. Pandemic flexibilities helped Americans access life-saving medications like buprenorphine without increasing misuse. So why are we going backward? The DEA’s newly proposed “guardrails” are more aptly “roadblocks” for addiction patients and providers alike.

The COVID-era PHE made SUD care accessible in a profound new way. But that could all change once the PHE expires. Boulder has been preparing to ensure continuity of care for our current and future patients and is actively advocating for better regulations to help all people in need of addiction care.

Mia Michalak, one of Boulder's clinicians, explains why a new, stronger version of the overdose medication, Narcan, may not be helpful to those who need it most.

Stephanie Strong, Boulder’s CEO, explains how powerful it was to hear President Biden acknowledge harm reduction and medicines to treat Opioid Use Disorder in his State of The Union speech, and what this change of heart could mean for the public health crisis going forward.